Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2020-01-20 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20200120 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB NV delivered its own shares to personnel exercising stock options under various LTI plans. This activity directly relates to the company managing its own share capital, specifically through share issuance/repurchase mechanisms related to employee compensation. This aligns perfectly with the definition of 'Transaction in Own Shares' (Code: POS). The document is a formal announcement dated January 20, 2020, providing detailed transaction tables, which confirms it is the primary disclosure, not just an announcement of a report (RPA/RNS).
2020-01-20 Dutch
200120-Transparency notification press release Blackrock .pdf
Director's Dealing Classification · 98% confidence The document is a 'Transparency notification' from BlackRock, Inc. to UCB SA/NV, dated January 20, 2020, detailing a change in shareholding that crossed the 5% threshold downwards on January 13, 2020. This type of filing, which reports changes in significant share ownership or insider transactions, aligns best with the 'Major Shareholding Notification' category (MRQ). It is not an earnings release, annual report, or a general regulatory announcement (RNS), but a specific disclosure regarding ownership thresholds.
2020-01-20 English
200120- Notification de transparence comm.de presse Blackrock.pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Déclaration de transparence' (Transparency Declaration) issued by UCB SA, announcing that BlackRock, Inc. has crossed a threshold (5%) downwards regarding its shareholding in UCB. This type of filing, which reports changes in significant share ownership levels by an external entity (BlackRock) crossing regulatory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). The text explicitly mentions 'seuil franchi : 5%' and details the change in voting rights and financial instruments held by BlackRock's related entities.
2020-01-20 French
200120 -Transparantieverklaring persbericht Blackrock .pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Transparantieverklaring' (Transparency Declaration) issued by UCB NV, announcing that BlackRock, Inc. has notified them of a change in shareholding that resulted in crossing below the 5% threshold ('Overschreden drempel: 5%', 'Laatste deelneming: 4,91%'). This type of filing, which reports changes in significant share ownership levels by external entities (like BlackRock), directly corresponds to the definition of Major Shareholding Notification (MRQ). The document details the previous and current number of voting rights and financial instruments held by the entity and its affiliates, confirming it is a notification of a change in major shareholding.
2020-01-20 Dutch
20100113- Disposal of own shares.pdf
Transaction in Own Shares Classification · 98% confidence The document is a regulated information press release dated January 13, 2020, detailing the disposal of UCB shares OTC following the exercise of stock options by employees under various Long Term Incentive (LTI) Plans. This transaction involves executives or directors dealing in company shares as part of compensation/incentive schemes. This directly aligns with the definition of 'Director's Dealing' (insider trades/executive share transactions). The code for this is DIRS. The document is short and is a direct announcement, not a general regulatory filing fallback (RNS).
2020-01-13 English
20200113 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA alienated (sold/issued) its own shares following option exercises by personnel, specifically mentioning these actions are in the context of variable long-term remuneration. The date is January 13, 2020, and it is classified as "information réglementée" (regulated information). This activity—the company buying back or issuing its own shares, often related to employee stock plans—directly corresponds to the definition of 'Transaction in Own Shares'.
2020-01-13 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.